“Be fearful when others are greedy, and be greedy when others are fearful.” – Warren Buffett
Repros Therapeutics Inc. (NASDAQ: RPRX) reminds investors that it will hold an Analyst and Investor Day on Wednesday, January 25, 2012.
Presentations will be from 9:00am to 12:00pm (EST) at the Millennium Broadway Hotel located at 145 West 44th Street, NYC.
The Company has arranged for outside Key Opinion Leaders (KOLs) to be present to discuss the Company’s clinical programs for both Androxal® and Proellex®.
Space at the event is limited and requests to attend from institutional investors and sell side analysts should be sent to email@example.com.
This event will also be broadcast live on the company’s web site at www.reprosrx.com beginning at 9:00am the day of the event.
AimHighProfits.com strives to provide you with the hottest stock alerts in the market in Real-Time. We focus on stocks that trade for $5 per share or less, some as little as a few pennies with upside potential. Our goal is committed to producing and publishing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions and to inform you of the best stocks in the market before they move. Our focus is primarily on OTC stocks in the stock market today which have traditionally been ignored by Wall Street.
We have particular expertise with internet stocks, gold stocks, renewable energy stocks, biotech stocks, oil stocks and green energy stocks. There are many hot penny stock opportunities present in the OTC market every day and we seek to exploit these hot stock gains for our members before the average daytrader is made aware of them.
Aim High Profits Disclaimer
This is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
AimHighProfits.com is a wholly-owned subsidiary of Kelevra Media Innovation.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
For a complete explanation, please visit our disclaimer page.Share